Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Long-Term Debt Issuances (2016 - 2024)

Fortress Biotech has reported Long-Term Debt Issuances over the past 11 years, most recently at -$33.7 million for Q4 2024.

  • Quarterly results put Long-Term Debt Issuances at -$33.7 million for Q4 2024, down 220.42% from a year ago — trailing twelve months through Sep 2024 was $61.7 million (up 1134.36% YoY), and the annual figure for FY2023 was $28.0 million, up 460.0%.
  • Long-Term Debt Issuances for Q4 2024 was -$33.7 million at Fortress Biotech, down from $33.7 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for FBIO hit a ceiling of $33.7 million in Q3 2024 and a floor of -$33.7 million in Q4 2024.
  • Median Long-Term Debt Issuances over the past 4 years was $7.0 million (2021), compared with a mean of $5.7 million.
  • Biggest five-year swings in Long-Term Debt Issuances: skyrocketed 460.0% in 2023 and later plummeted 220.42% in 2024.
  • Fortress Biotech's Long-Term Debt Issuances stood at $7.0 million in 2021, then fell by 28.57% to $5.0 million in 2022, then skyrocketed by 460.0% to $28.0 million in 2023, then plummeted by 220.42% to -$33.7 million in 2024.
  • The last three reported values for Long-Term Debt Issuances were -$33.7 million (Q4 2024), $33.7 million (Q3 2024), and $28.0 million (Q4 2023) per Business Quant data.